Fariba Bayat

and 5 more

IntroductionGranulomatosis with polyangiitis (GPA) is a chronic condition characterized by granulomatous inflammation of blood vessels, leading to damage in various organs, including the lungs, kidneys, and sinuses. This pattern of involvement can complicate the diagnosis of coexisting conditions, especially those involving granulomatous inflammation, like tuberculosis (TB). Its treatment typically involves the use of immunosuppressants, which can further complicate the diagnosis of infectious conditions. (1) Cardiac tuberculosis (TB) is a rare but clinically significant extrapulmonary manifestation of tuberculosis, often presenting substantial diagnostic challenges due to its nonspecific symptoms. Timely diagnosis and management are crucial as TB’s involvement in cardiac tissues can result in severe complications such as tuberculous pericarditis and cardiac tamponade. (2) Patients may exhibit symptoms like fatigue, weight loss, dyspnea, and chest pain, which can easily mimic other cardiac conditions, complicating both diagnosis and management. The prevalence of cardiac TB varies geographically, with notably higher rates observed in regions where TB is endemic. (2) In addition to cardiac TB, mitral-aortic intervalvular abscesses represent another rare yet critical complication associated with infective endocarditis, particularly in patients with pre-existing cardiovascular disease. This anatomical region, known as the mitral-aortic intervalvular fibrosa (MAIVF), consists of fibrous and avascular tissue that is particularly vulnerable to infections and trauma. These abscesses occur in less than 1% of endocarditis cases and can lead to severe sequelae, such as valvular dysfunction and heart failure, if not diagnosed and treated promptly. (3, 4)The primary causative agents are often bacterial infections, particularly from organisms like Staphylococcus aureus. These infections can invade the fibrous tissue following surgical interventions or arise in the context of chronic conditions that predispose patients to endocarditis.(5, 6) The co-occurrence of tuberculosis (TB) and granulomatosis with polyangiitis (GPA) presents a significant clinical challenge, especially among immunocompromised patients. This case report details a 45-year-old woman with end-stage renal disease secondary to GPA who developed an MAIVF abscess with necrotizing granulomatosis inflammation and a positive tissue PCR for TB. Understanding the interplay between these two conditions is critical for guiding distinct therapeutic approaches, given that both involve granulomatous inflammation.

Vahid Eslami

and 6 more

Objective There are some suggestions that global myocardial strain (GLS) early after ST-elevation myocardial infarction (STEMI) is a predictor of improvement in left ventricular ejection fraction (LVEF) after myocardial infarction. The goal of this study was to evaluate predictive value of GLS in patient with STEMI. Methods The study population consists of 43 patients with acute STEMI and no history of prior coronary intervention treated with primary percutaneous coronary intervention. LVEF and myocardial strain indices were measured 48hours and two months after STEMI by transthoracic echocardiography and speckle tracking method. More than 5% improvement in LV EF was considered significant improvement. Results GLS values were significantly higher in patients with >5% improvement in LVEF 2 months after the STEMI (GLS=15.76% in patients with >5% improvement vs. 11.54% in the other group,P <0.05). ROC analysis suggested GLS values more than 13.5 to be a predictor of significant LVEF improvement 2 month after STEMI. Higher GLS was observed in patients with inferior, posterior and inferoseptal STEMI versus anterior, extensive or anteroseptal STEMI and in patients with right coronary occlusion versus occlusion of the left anterior descending or circumflex arteries. Conclusion We have observed that early longitudinal LV strain after STEMI is a predictor of during first 2 months after STEMI. This is a useful method to predict early LV recovery after STEMI. GLS values more than 13.5%is a significant predictor of significant LVEF improvement.